Children with Chronic Myeloid Leukemia - CML
SITES
International CML Foundation - Section on Pediatric CML
Junior CML Advocates
Children with cancer (UK)
Registration of Children With CML and Treatment With Imatinib (CML-paed II)
Seattle Cancer Care Alliance – Pediatrics (US)
Children's Hospital Boston
The International BFM Study Group
Aaron Bullingham’s site
Isabella Juliette Babione’s site
Medical Resources: Understanding Leukemia by Online Nursing Degrees
International CML Foundation - Section on Pediatric CML
Junior CML Advocates
Children with cancer (UK)
Registration of Children With CML and Treatment With Imatinib (CML-paed II)
Seattle Cancer Care Alliance – Pediatrics (US)
Children's Hospital Boston
The International BFM Study Group
Aaron Bullingham’s site
Isabella Juliette Babione’s site
Medical Resources: Understanding Leukemia by Online Nursing Degrees
FORUMS
Children with CML by CML Support (UK)
Cancercompass(Child1- before 20 years old)
Cancercompass(Child2 - after 20 years old)
-----------------------
Children with CML in Facebook (new group) (old group)
Mary Sullivan 2 years old - story in Facebook
Children with CML by CML Support (UK)
Cancercompass(Child1- before 20 years old)
Cancercompass(Child2 - after 20 years old)
-----------------------
Children with CML in Facebook (new group) (old group)
Mary Sullivan 2 years old - story in Facebook
"If you or a family member has been diagnosed with a blood cancer, you may find it helpful to speak with someone who has gone through a similar experience and learned how to manage the same disease you're trying to cope with each day. The Patti Robinson Kaufmann First Connection Program is a free service of The Leukemia & Lymphoma Society (LLS) that matches patients and their loved ones with trained peer volunteers who have shared similar experiences.
Extract of Peer-to-peer Support - The Leukemia & Lymphoma Society (LLS)
VIDEOS
EHA 2019: Special aspects in children (Fréderic Millot) -Mechanisms for Resistance and TFR in CML: Special Aspects in Children
2020, iCMLf
Pediatric CML
November 2019, iCMLf
New findings on the Philadelphia chromosome
September 17, 2018, UFHealth
The Bone Marrow - Factory of Life (for children)
November 22, 2011, sodasystem
Cancer survivors beat the odds, graduate high school
June 19, 2011, Today
Believe in tomorrow
September 4, 2008, believeintomorrow
EHA 2019: Special aspects in children (Fréderic Millot) -Mechanisms for Resistance and TFR in CML: Special Aspects in Children
2020, iCMLf
Pediatric CML
November 2019, iCMLf
New findings on the Philadelphia chromosome
September 17, 2018, UFHealth
The Bone Marrow - Factory of Life (for children)
November 22, 2011, sodasystem
Cancer survivors beat the odds, graduate high school
June 19, 2011, Today
Believe in tomorrow
September 4, 2008, believeintomorrow
ARTICLES
Discontinuation of Imatinib in Children with Chronic Myeloid Leukemia: An International Registry of Childhood Chronic Myeloid Leukemia (I-CML-Ped) Study
December 5, 2020, ASH2020
Vaccination With Live Attenuated Vaccines in Four Children With Chronic Myeloid Leukemia While on Imatinib Treatment
April 2020, Frontiers in Immunology
Sustained Molecular Response Following a Failed Attempt of Tyrosine Kinase Inhibitor Discontinuation & the Effects on Growth in a Child With Chronic Myeloid Leukemia: Not Always a Short Story
April 29, 2020, PubMed
Coronavirus: 'I'm self-isolating - but I have 26 pen pals’ – Teenager with CML'
March 22, 2020, BBC News
Pharmacokinetics of Nilotinib in Pediatric Patients with Philadelphia Chromosome–Positive Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia
March 3, 2020, Clinical Cancer Research
Results and outcome of intermittent imatinib (ON/OFF schedule) in children and adolescents with chronic myeloid leukaemia
February 22, 2020, BJH
Experience with ponatinib in paediatric patients with leukaemia
January 24, 2020, BJH
Nilotinib Therapy Safe, Effective for Certain Patients With CML
January 16, 2020, Oncology Learning Network
Acquired von Willebrand Syndrome in Pediatric Patients With Chronic Myeloid Leukemia
November 7, 2019, Hematology Advisor
Leukemia and Childhood Infection Hypothesis
Jul 30, 2019, News Medical
Risk of Hospitalization Remains High for Survivors of Childhood Leukemia
February 21, 2019, Oncology Nurse Advisor
Physiologically based pharmacokinetic modeling to supplement nilotinib pharmacokinetics and confirm
dose selection in pediatric patients
February 4, 2019, PubMed
Addressing Off-Target Effects of TKIs in Pediatric CML
December 10, 2018, OncLive
Practice Patterns of Physician Treatment for Pediatric Chronic Myeloid Leukemia (CML)
September 26, 2018, PubMed
Research Indicates Imatinib Is Effective in Pediatric Patients With Chronic Phase CML
July 19, 2018, Cancer Therapy Advisor
EC approves expanded indication for Sprycel
July 6, 2018, thepharmaletter
Dasatinib Approved in Europe for Pediatric Ph+ Chronic Phase CML
July 5, 2018, OncLive
Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial
June 20, 2018, Leukemia
Pediatric CML: Life-Long Considerations With TKI Therapy
May 22, 2018, Cancer Therapy Advisor
Tasigna cleared for use in children with rare leukemia
March 23, 2018, PharmaTimes
FDA Approves Nilotinib for Pediatric Chronic Myeloid Leukemia
March 22, 2018, Oncology Nursing News
Dasatinib: A Safe and Effective Option for Pediatric CML
March 5, 2018, Cancer Therapy Advisor
Pediatric CML: Imatinib Effective in the Front Line
February 22, 2018, Cancer Therapy Advisor
Advanced Phases at Diagnosis of Childhood Chronic Myeloid Leukemia : The Experience of the International
Registry for Chronic Myeloid Leukemia (CML) in Children and Adolescents (I-CML-Ped Study)
December 2017, ASH 2017
Long-Term Outcome in Children and Adolescents with Chronic Myeloid Leukemia in Chronic Phase Treated with High-Dose Imatinib. the Italian Experience
December 2017, ASH 2017
Family, community rally around Bessemer girl battling leukemia
December 16 2016, New Castle News
Childhood CML Survival Worst for Children Under 5 Years Old
October 19, 2016, Cancer Therapy Advisor
Disparities in Childhood CML Outcomes Persist Among Some European Countries and the US
October 11, 2016, Cancer Therapy Advisor
Pediatric chronic myeloid leukemia is a unique disease that requires a different approach
October 23, 2015, Journal Blood
Cord Blood Transplant: In Children, One Will Do
October 29, 2014, Medscape
Waterloo girl receives trip of a lifetime
November 21, 2013, hngnews.com
Imatinib cessation in children and adolescents with chronic myeloid leukemia in chronic phase
September 17, 2013, Pediatric Blood & Cancer
Dasatinib Shows Promise for Pediatric CML, ALL Patients
September 13, 2013, Cancer Network
Chronic myeloid leukemia in children and adolescents: Results of treatment with imatinib mesylate.
May 18, 2012, PubLmed
How I treat childhood CML
February 22, 2012, Journal Blood
Analysis of outcomes in adolescents and young adults with CML treated with upfront tyrosine kinase inhibitortherapy
January 22, 2012,Heamatologica
Imatinib has adverse effect on growth in children with chronic myeloid leukemia.
November 2, 2011, Pediatr Blood Cancer.
Imatinib Is Effective in Children With Previously Untreated Chronic Myelogenous Leukemia in Early Chronic Phase: Results of the French National Phase IV Trial
June 20, 2011, Journal of Clinical Oncology
Imatinib Is Effective in Children With Previously Untreated Chronic Myelogenous Leukemia in Early Chronic Phase: Results of the French National Phase IV Trial
May 5, 2011, Journal of Clinical Oncology
Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation
March 25, 2011, PublMed
Controversies in the treatment of CML in children and adolescents: TKIs versus BMT?
January 17, 2011, Unbound Medline
Excellent outcomes of children with CML treated with imatinib mesylate compared to that in pre-imatinib era;
January 2011, International journal of hematology
Treatment of Pediatric Chronic Myeloid Leukemia in the Year 2010: Use of Tyrosine Kinase Inhibitors and Stem-Cell Transplantation
December 2010, Hematology
Acquired growth hormone deficiency in a girl with chronic myelogenous leukemia treated with tyrosine kinase inhibitor therapy.
December 22, 2010, Unbound Medline
Distinct Impact of Imatinib on Growth In Prepubertal and Pubertal Children with Chronic Myeloid Leukemia
December 5, 2010, ASH2010
Dasatinib In Children and Adolescents with Relapsed or Refractory Leukemia: Results of the CA180018 Phase 1 Dose-Escalation Study of the Innovative Therapies for Children with Cancer (ITCC) Consortium
December 5, 2010, ASH 2010
Treatment of Pediatric Chronic Myeloid Leukemia in the Year 2010: Use of Tyrosine Kinase Inhibitors and Stem-Cell Transplantation
December 4, 2010,Hematology
Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies Treatment
October 2010 (last modified), National Cancer Institute
Clinical characteristics and treatment outcome of pediatric patients with chronic myeloid leukemia
April 21, 2010, Haematologica
Impact of the type of the BCR-ABL fusion transcript on the molecular response in paediatric patients with chronic myeloid leukemia
February 2010, Haematologica
Outcome of 125 children with chronic myelogenous leukemia who received transplants from unrelated donors: the Japan Marrow Donor Program.
February 2010, PubLMed.com
Imatinib Is Efficient but Has a Negative Impact On Growth in Children with Previously Untreated chronic Myelogenous Leukaemia (CML) in Early Chronic Phase (CP): Results of the French National Phase IV Trial
December 2009, ASH 2009
Allogeneic stem cell transplantation for pediatric and adolescent patients with CML: results from the prospective trial CML-paed I
November 2009, PubMed
Growth deceleration in a girl treated with imatinib
January 20, 2009, The Japanese Society of Hematology
Molecular response of pediatric chronic myeloid leukemia (CML) with imatinib mesylate therapy
November 2008, Cancer Prevention research
Dasatinib in children and adolescents with relapsd or refractory leukemia preliminary results of the CA180018 PHASE I/II study from the ITCC CONSORTIUM
June 2008, 13th Congress of the European Hematology Association
Leucostase pulmonaire au cours d'une leucémie myéloïde chronique (in French)
2006, Santé tropicale.com
Clinical and Biological Features at Diagnosis in 40 Children With Chronic Myeloid Leukemia
July 2005 , Pediatrics
Treatment of CML in pediatric patients: should imatinib mesylate (STI-571, Gleevec) or allogeneic hematopoietic cell transplant be front-line therapy?
October 2004, PubLmed.gov
Early blastic transformation following complete cytogenetic response in a pediatric chronic myeloid leukemia patient treated with imatinib mesylate.
May 2004, PubLMed.gov
Build it and they will come (or will they?)
August 2003, Journal Blood
Stem cell transplantation for chronic myeloid leukemia in children
August 15, 2003, Journal Blood
Discontinuation of Imatinib in Children with Chronic Myeloid Leukemia: An International Registry of Childhood Chronic Myeloid Leukemia (I-CML-Ped) Study
December 5, 2020, ASH2020
Vaccination With Live Attenuated Vaccines in Four Children With Chronic Myeloid Leukemia While on Imatinib Treatment
April 2020, Frontiers in Immunology
Sustained Molecular Response Following a Failed Attempt of Tyrosine Kinase Inhibitor Discontinuation & the Effects on Growth in a Child With Chronic Myeloid Leukemia: Not Always a Short Story
April 29, 2020, PubMed
Coronavirus: 'I'm self-isolating - but I have 26 pen pals’ – Teenager with CML'
March 22, 2020, BBC News
Pharmacokinetics of Nilotinib in Pediatric Patients with Philadelphia Chromosome–Positive Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia
March 3, 2020, Clinical Cancer Research
Results and outcome of intermittent imatinib (ON/OFF schedule) in children and adolescents with chronic myeloid leukaemia
February 22, 2020, BJH
Experience with ponatinib in paediatric patients with leukaemia
January 24, 2020, BJH
Nilotinib Therapy Safe, Effective for Certain Patients With CML
January 16, 2020, Oncology Learning Network
Acquired von Willebrand Syndrome in Pediatric Patients With Chronic Myeloid Leukemia
November 7, 2019, Hematology Advisor
Leukemia and Childhood Infection Hypothesis
Jul 30, 2019, News Medical
Risk of Hospitalization Remains High for Survivors of Childhood Leukemia
February 21, 2019, Oncology Nurse Advisor
Physiologically based pharmacokinetic modeling to supplement nilotinib pharmacokinetics and confirm
dose selection in pediatric patients
February 4, 2019, PubMed
Addressing Off-Target Effects of TKIs in Pediatric CML
December 10, 2018, OncLive
Practice Patterns of Physician Treatment for Pediatric Chronic Myeloid Leukemia (CML)
September 26, 2018, PubMed
Research Indicates Imatinib Is Effective in Pediatric Patients With Chronic Phase CML
July 19, 2018, Cancer Therapy Advisor
EC approves expanded indication for Sprycel
July 6, 2018, thepharmaletter
Dasatinib Approved in Europe for Pediatric Ph+ Chronic Phase CML
July 5, 2018, OncLive
Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial
June 20, 2018, Leukemia
Pediatric CML: Life-Long Considerations With TKI Therapy
May 22, 2018, Cancer Therapy Advisor
Tasigna cleared for use in children with rare leukemia
March 23, 2018, PharmaTimes
FDA Approves Nilotinib for Pediatric Chronic Myeloid Leukemia
March 22, 2018, Oncology Nursing News
Dasatinib: A Safe and Effective Option for Pediatric CML
March 5, 2018, Cancer Therapy Advisor
Pediatric CML: Imatinib Effective in the Front Line
February 22, 2018, Cancer Therapy Advisor
Advanced Phases at Diagnosis of Childhood Chronic Myeloid Leukemia : The Experience of the International
Registry for Chronic Myeloid Leukemia (CML) in Children and Adolescents (I-CML-Ped Study)
December 2017, ASH 2017
Long-Term Outcome in Children and Adolescents with Chronic Myeloid Leukemia in Chronic Phase Treated with High-Dose Imatinib. the Italian Experience
December 2017, ASH 2017
Family, community rally around Bessemer girl battling leukemia
December 16 2016, New Castle News
Childhood CML Survival Worst for Children Under 5 Years Old
October 19, 2016, Cancer Therapy Advisor
Disparities in Childhood CML Outcomes Persist Among Some European Countries and the US
October 11, 2016, Cancer Therapy Advisor
Pediatric chronic myeloid leukemia is a unique disease that requires a different approach
October 23, 2015, Journal Blood
Cord Blood Transplant: In Children, One Will Do
October 29, 2014, Medscape
Waterloo girl receives trip of a lifetime
November 21, 2013, hngnews.com
Imatinib cessation in children and adolescents with chronic myeloid leukemia in chronic phase
September 17, 2013, Pediatric Blood & Cancer
Dasatinib Shows Promise for Pediatric CML, ALL Patients
September 13, 2013, Cancer Network
Chronic myeloid leukemia in children and adolescents: Results of treatment with imatinib mesylate.
May 18, 2012, PubLmed
How I treat childhood CML
February 22, 2012, Journal Blood
Analysis of outcomes in adolescents and young adults with CML treated with upfront tyrosine kinase inhibitortherapy
January 22, 2012,Heamatologica
Imatinib has adverse effect on growth in children with chronic myeloid leukemia.
November 2, 2011, Pediatr Blood Cancer.
Imatinib Is Effective in Children With Previously Untreated Chronic Myelogenous Leukemia in Early Chronic Phase: Results of the French National Phase IV Trial
June 20, 2011, Journal of Clinical Oncology
Imatinib Is Effective in Children With Previously Untreated Chronic Myelogenous Leukemia in Early Chronic Phase: Results of the French National Phase IV Trial
May 5, 2011, Journal of Clinical Oncology
Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation
March 25, 2011, PublMed
Controversies in the treatment of CML in children and adolescents: TKIs versus BMT?
January 17, 2011, Unbound Medline
Excellent outcomes of children with CML treated with imatinib mesylate compared to that in pre-imatinib era;
January 2011, International journal of hematology
Treatment of Pediatric Chronic Myeloid Leukemia in the Year 2010: Use of Tyrosine Kinase Inhibitors and Stem-Cell Transplantation
December 2010, Hematology
Acquired growth hormone deficiency in a girl with chronic myelogenous leukemia treated with tyrosine kinase inhibitor therapy.
December 22, 2010, Unbound Medline
Distinct Impact of Imatinib on Growth In Prepubertal and Pubertal Children with Chronic Myeloid Leukemia
December 5, 2010, ASH2010
Dasatinib In Children and Adolescents with Relapsed or Refractory Leukemia: Results of the CA180018 Phase 1 Dose-Escalation Study of the Innovative Therapies for Children with Cancer (ITCC) Consortium
December 5, 2010, ASH 2010
Treatment of Pediatric Chronic Myeloid Leukemia in the Year 2010: Use of Tyrosine Kinase Inhibitors and Stem-Cell Transplantation
December 4, 2010,Hematology
Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies Treatment
October 2010 (last modified), National Cancer Institute
Clinical characteristics and treatment outcome of pediatric patients with chronic myeloid leukemia
April 21, 2010, Haematologica
Impact of the type of the BCR-ABL fusion transcript on the molecular response in paediatric patients with chronic myeloid leukemia
February 2010, Haematologica
Outcome of 125 children with chronic myelogenous leukemia who received transplants from unrelated donors: the Japan Marrow Donor Program.
February 2010, PubLMed.com
Imatinib Is Efficient but Has a Negative Impact On Growth in Children with Previously Untreated chronic Myelogenous Leukaemia (CML) in Early Chronic Phase (CP): Results of the French National Phase IV Trial
December 2009, ASH 2009
Allogeneic stem cell transplantation for pediatric and adolescent patients with CML: results from the prospective trial CML-paed I
November 2009, PubMed
Growth deceleration in a girl treated with imatinib
January 20, 2009, The Japanese Society of Hematology
Molecular response of pediatric chronic myeloid leukemia (CML) with imatinib mesylate therapy
November 2008, Cancer Prevention research
Dasatinib in children and adolescents with relapsd or refractory leukemia preliminary results of the CA180018 PHASE I/II study from the ITCC CONSORTIUM
June 2008, 13th Congress of the European Hematology Association
Leucostase pulmonaire au cours d'une leucémie myéloïde chronique (in French)
2006, Santé tropicale.com
Clinical and Biological Features at Diagnosis in 40 Children With Chronic Myeloid Leukemia
July 2005 , Pediatrics
Treatment of CML in pediatric patients: should imatinib mesylate (STI-571, Gleevec) or allogeneic hematopoietic cell transplant be front-line therapy?
October 2004, PubLmed.gov
Early blastic transformation following complete cytogenetic response in a pediatric chronic myeloid leukemia patient treated with imatinib mesylate.
May 2004, PubLMed.gov
Build it and they will come (or will they?)
August 2003, Journal Blood
Stem cell transplantation for chronic myeloid leukemia in children
August 15, 2003, Journal Blood
